Joshua Riggs
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joshua Riggs
Joshua Riggs is recorded as CEO and Board Member at Insight Molecular Diagnostics Inc. (IMDX). Insight Molecular Diagnostics Inc. reported in an 8-K filed June 17, 2026 that Joshua Riggs was appointed director, effective June 11, 2026. Insight Molecular Diagnostics Inc. reported in an 8-K filed June 9, 2023 that Joshua Riggs was appointed Chief Executive Officer, effective June 6, 2023. Insight Molecular Diagnostics Inc. reported in an 8-K filed June 9, 2023 that Joshua Riggs was appointed Chief Executive Officer, effective February 24, 2023. Equibles holds 7 filed executive changes naming Joshua Riggs; each is listed under recent activity with its source filing. The proxy statement of Insight Molecular Diagnostics Inc. reports total compensation of $2,594,786 for Joshua Riggs in fiscal 2025, including a base salary of $472,293. Disclosed compensation is on record for 4 fiscal years.
“each director nominee was duly elected to serve until the 2027 annual meeting of shareholders and until his successor has been elected and qualified, or until his earlier death, resignation, or removal.”
“In consideration of my promotion to Chief Executive Officer and continued employment by ONCOCYTE CORPORATION its subsidiaries, parents, affiliates, successors and assigns (together "Company") pursuant to the Employment Agreement effective as of June 6, 2023”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-28–present
-
Current
2023-01-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Insight Molecular Diagnostics Inc.
Other people whose current roles at this company are on record from its filings.
- Ronald Andrews CEO
- Andrew Arno Chairman, Board Member
- Andrea James CFO
- James Liu CFO, Chief Accounting Officer
- Mitchell Levine CFO
- Gisela A. Paulsen COO
- Gisela Paulsen COO
- Li Yu Chief Accounting Officer
- Andrew J. Last Board Member
- Jennifer Levin Carter, MD Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Insight Molecular Diagnostics Inc. (IMDX) | President & Chief Executive Officer | $472,293 | $2,594,786 |
| 2024 | Insight Molecular Diagnostics Inc. (IMDX) | President and Chief Executive Officer | $385,018 | $786,077 |
| 2023 | Insight Molecular Diagnostics Inc. (IMDX) | President and Chief Executive Officer | $339,846 | $724,910 |
| 2022 | Insight Molecular Diagnostics Inc. (IMDX) | President and Chief Executive Officer | $242,028 | $514,110 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.